1Amarenco P,Bogousslavsky J,Callahan A 3rd,et al.High-dose atorvastatin after stroke or transient ischemic attack[J].N Engl J Med,2006,355(6).549-559.
2Amarenco P,Labreuche J,Lavallee P,et al.Statinsin stroke prevention and carotid atherosclerosis:systematic review and up-to-date meta-analysis[J].Stroke,2004,35(12):2902-2909.
3Cannon CP,Steinberg BA,Murphy SA,et al.Metaanalysis of cardiovascular outcomes trials comparing intensive versus moderate statin therapy[J].J Am Coll Cardiol,2006,48(3):438-445.
4Stein E.Cerivastatin in primary hyperlipidemia:a multicenter analysis of efficacy and safety[J].Am J Cardiol,1998,82(4B):40J-46J.
5Lye M,Valacio R,Reckless JP,et al.Elderly patients with hypercholesterolaemia:a double-blind study of efficacy,safety and tolerability of fluvastatin[J].Coron Artery Dis,1998,9(9):583-590.
6Newman CB,Palmer G,Silbershatz H,et al.Safety of atorvastatin derived from analysis of 44 completed trials in 9416 patients[J].Am J Cardiol,2003,92(6):670-676.
7Pasternak RC,Smith SC Jr,Bairey-Merz CN,et al.ACC/AHA/NHLBI clinical advisory on the use and safety of statins[J].JACC,2002,40(3):567-572.
8National Cholesterol Education Program (NCEP) Expert Panel on Detection,Evaluation,and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel Ⅲ).Third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection,Evaluation,and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel Ⅲ) final report.[J].Circulation,2002,106(25):3143-3421.
9Bradford RH,Shear CL,Chremos AN,et al.Expanded Clinical Evaluation of Lovastatin (EXCEL) study results.Ⅰ.Efficacy in modifying plasma lipoproteins and adverse event profile in 8245 patients with moderate hypercholesterolemia[J].Arch Intern Med,1991,151(1):43-49.
10Brass LM,Alberts MJ,Sparks L,et al.An assessment of statin safety by neurologists[J].Am J Cardiol,2006,97(8A):86C-88C.
